Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
Format: | Article |
---|---|
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000756 |
Similar Items
-
Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?
by: Jannik Stemler, et al.
Published: (2022-07-01) -
The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study
by: Vildan Özkocaman, et al.
Published: (2018-11-01) -
Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia
by: Mayur D. Mody MD, et al.
Published: (2017-02-01) -
THE EFFICACY OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: G. A. Klyasova, et al.
Published: (2017-11-01) -
Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents
by: Ka-Won Kang, et al.
Published: (2020-10-01)